United States · Series A startup

Who invested in Red Queen Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$55Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $55MAug 2024
Investors
0
See who backed them

The rounds

  1. Aug 2024
    Series A$55M

    No investor was named in the report.

    Source recorded

Funding filed with regulators

Red Queen Therapeutics filed one raise, $5.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Oct 2021$5.0M1 investorequityof $55M offeredSEC Form D

Founders and team

From the SEC filings it signed: 1 on the team.

  • Paul Da Silva JardineExecutive Officer, Directori

On the board, as filediLoren WalenskySeth HarrisonSpiros Liras

Quick answers about Red Queen Therapeutics

How much has Red Queen Therapeutics raised?

Red Queen Therapeutics has raised $55M across 1 round since 2024.

When did Red Queen Therapeutics last raise?

Red Queen Therapeutics's most recent round was a Series A of $55M in Aug 2024.

What was Red Queen Therapeutics's biggest round?

Its most recent round, $55M in Aug 2024, is also its largest on record.

What stage is Red Queen Therapeutics at?

Red Queen Therapeutics's latest named round is a Series A, in Aug 2024.

Where is Red Queen Therapeutics based?

Red Queen Therapeutics is based in the United States.

Companies like Red Queen Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.